Tang Capital Management LLC
Tang Capital Management LLC is a private investment firm headquartered in San Diego, California. The firm is primarily focused on investing in the healthcare and biotechnology sectors, managing a diverse portfolio of public equities. Founded in the early 2000s, Tang Capital is known for its highly research-driven and concentrated investment approach, serving institutional investors and sophisticated individuals. The firm's strategies often involve active engagement with its portfolio companies, leveraging deep expertise in life sciences and biopharma. Employee count is not publicly disclosed but is estimated to be under 25.
Investment Strategy
Tang Capital Management LLC pursues a fundamental, research-intensive investment strategy with a core focus on healthcare and biotechnology. The firm typically invests in innovative, high-growth companies, often taking large, concentrated positions. Tang Capital seeks to create value through active participation in corporate events and capital markets transactions, including PIPEs and SPACs, and at times playing an activist role to influence strategic decisions. The investment team combines scientific understanding with financial analysis to identify undervalued opportunities within the life sciences sector.
Latest 13F Filing Activity
Tang Capital Management LLC filed their most recent 13F report on Jun 30, 2025 disclosing 197 equity positions with a total 13F market value of $2B. The fund increased holdings in Vera Therapeutics Inc. CL A, Merus N V, Mettler-toledo International among other positions. Tang Capital Management LLC reduced exposure to Dynavax Technologies Corp., Intra-cellular Therapies Inc., Tarsus Pharmaceuticals Inc. among others.
Top Holdings
Equity Positions (197)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
G GLPG | GALAPAGOS NV | 5.65% | $111.7M | 3,990,111 | $26.60 | $27.99 | +$12.2M |
T TARS | TARSUS PHARMACEUTICALS INC | 5.03% | $99.4M | 2,454,797 | $18.85 | $40.51 | -$26.7M |
A AUPH | AURINIA PHARMACEUTICALS INC | 4.29% | $84.9M | 10,029,500 | $7.26 | $8.47 | +$4.3M |
I IMCR | IMMUNOCORE HLDGS PLC | 3.34% | $66.1M | 2,105,608 | $30.48 | $31.38 | +$9.2M |
K KNSA | KINIKSA PHARMACEUTICALS INTL | 3.26% | $64.4M | 2,328,609 | $21.58 | $27.67 | +$17.4M |